Doctor profile · Federal record
Dr. Diana Tenpenny, DO
Endocrinology, Diabetes & Metabolism Physician (CMS: Internal Medicine) · Internal Medicine Physician · East Stroudsburg, PA
- NPI 1265846539
- Accepts Medicare
- MIPS 78.7 / 100 · 2023
- 17 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
179 Independence RD
East Stroudsburg, PA 183019207
(570) 426-2330
fax (570) 426-2331 - Additional location
-
18 E Laurel RD
Stratford, NJ 080841327
(856) 513-4124 - Additional location
-
42 E Laurel RD
Stratford, NJ 080841354
(856) 566-2753
Credentials & registration
- NPI registered
- June 2014 — 12 yrs on file
- Profile last updated
- February 1, 2023
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State licenses (2)
- Pennsylvania #OS020906 · New Jersey #25MB09987200
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1265846539. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,038
Distinct HCPCS
10
Medicare allowed
$83,504
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,560 | 20 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 215 | 155 | $124 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 75 | 43 | $34 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 66 | 53 | $174 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 29 | 29 | $162 | |
96372 |
Injection of drug or substance under skin or into muscle | 26 | 20 | $13 | |
99451 |
Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 20 | 20 | $33 | |
83036 |
Hemoglobin a1c level | 16 | 15 | $10 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 16 | 16 | $88 | |
82044 |
Urine microalbumin (protein) analysis | 15 | 15 | $6 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 203. This provider delivers 10× the peer median.Open Payments
Industry payments received
All-time total
$175
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Tandem Diabetes Care, Inc. | 1 | $114.49 | |
| Ipsen Biopharmaceuticals, Inc | 1 | $60.50 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,732
Patients
522
Total drug cost
$1,146,429
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 189 | 66 | $3,643 |
| Trulicity (Dulaglutide) | Brand | 177 | 42 | $287,434 |
| Metformin Hcl | Generic | 167 | 49 | $1,915 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 154 | 44 | $103,531 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 136 | 54 | $14,743 |
| Ozempic (Semaglutide) | Brand | 122 | 32 | $180,097 |
| Glipizide | Generic | 116 | 34 | $2,029 |
| Jardiance (Empagliflozin) | Brand | 113 | 34 | $157,606 |
| Novolog Flexpen (Insulin Aspart) | Brand | 112 | 38 | $135,981 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 87 | 25 | $3,204 |
Frequently asked questions
What is Dr. Diana Tenpenny's medical specialty?
Dr. Diana Tenpenny practices Endocrinology, Diabetes & Metabolism Physician in East Stroudsburg, PA.
Where does Dr. Diana Tenpenny practice?
Dr. Diana Tenpenny practices at 179 Independence RD, East Stroudsburg, PA 183019207. Office phone: 5704262330.
What is Dr. Diana Tenpenny's NPI?
Dr. Diana Tenpenny's National Provider Identifier (NPI) is 1265846539, issued by NPPES.
Does Dr. Diana Tenpenny accept Medicare assignment?
Yes. Dr. Diana Tenpenny accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Diana Tenpenny commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.